|
| 37841855 | Neural Correlates of Positive and Negative Formal Thought Disorder in Individuals with Schizophrenia: An ENIGMA Schizophrenia Working Group Study. | Res Sq | 2023 |
| 34498337 | A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. | Hum Brain Mapp | 2022 |
| 35634535 | Joint-label fusion brain atlases for dementia research in Down syndrome. | Alzheimers Dement (Amst) | 2022 |
| 32857118 | Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. | JAMA Psychiatry | 2021 |
| 32435685 | Down syndrome: Distribution of brain amyloid in mild cognitive impairment. | Alzheimers Dement (Amst) | 2020 |
| 29935887 | A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS. | Schizophr Res | 2018 |
| 26586142 | Neuropsychological profile in adult schizophrenia measured with the CMINDS. | Psychiatry Res | 2015 |
| 23910899 | Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. | Biol Psychiatry | 2014 |
| 24650452 | A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. | Psychiatry Res | 2014 |
| 24332632 | Converting positive and negative symptom scores between PANSS and SAPS/SANS. | Schizophr Res | 2014 |
| 24073841 | D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder. | CNS Spectr | 2014 |
| 22343285 | Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. | Proc Natl Acad Sci U S A | 2012 |
| 19023125 | A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. | Schizophr Bull | 2009 |
| 18423611 | Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. | Psychiatry Res | 2008 |
| 17244173 | A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. | Acta Psychiatr Scand | 2007 |
| 16423163 | Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. | Acta Psychiatr Scand | 2006 |
| 16841629 | Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. | J Clin Psychiatry | 2006 |
| 16754415 | Dietary intake profile of patients with schizophrenia. | Ann Clin Psychiatry | 2006 |
| 16959041 | Brief screening for co-occurring disorders among women entering substance abuse treatment. | Subst Abuse Treat Prev Policy | 2006 |
| 16920075 | Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients. | Biol Psychiatry | 2006 |
| 16423166 | An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. | Acta Psychiatr Scand | 2006 |
| 16075662 | Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patient. | Ann Clin Psychiatry | 2005 |
| 15863798 | A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. | Am J Psychiatry | 2005 |
| 16187768 | Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. | J Clin Psychiatry | 2005 |